{"top_spans": [[0, 0], [0, 2], [0, 3], [8, 8], [9, 13], [12, 13], [14, 14], [15, 15], [15, 17], [19, 23], [19, 26], [19, 27], [21, 21], [21, 23], [21, 26], [21, 27], [21, 28], [26, 26], [29, 29], [29, 35], [34, 34], [44, 44], [50, 50], [51, 55], [51, 56], [51, 57], [57, 57], [58, 59], [60, 60], [68, 68], [69, 70], [80, 80]], "predicted_antecedents": [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1], "document": ["elanco", "animal", "health", "reports", "strong", "third", "quarter", "results", "provides", "financial", "guidance", "for", "full", "year", "2018", "greenfield", "ind", "business", "wire", "-nov", "6", "2018-elanco", "animal", "health", "incorporated", "nyse", "larchwood", "prevacent", "prrs", "greenfield", "animal", "therapeutics", "jeff", "simmons", "imvixa", "norwegian", "medicines", "agency", "elanco", "animal", "health", "incorporated", "nyse", "eli", "lilly", "and", "company", "european", "medicines", "agency", "novozymes", "asia", "securities", "and", "exchange", "commission", "ind", "norway", "u", "s", "credelio", "iowa", "product", "development", "elanco", "companion", "animal", "therapeutics", "trifexis", "greenfield", "indiana", "correlink", "eli", "lilly", "president", "and", "chief", "executive", "officer", "of", "elanco"], "clusters": []}